Mark Harland

6.9k total citations
43 papers, 1.3k citations indexed

About

Mark Harland is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Mark Harland has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 22 papers in Molecular Biology and 18 papers in Cancer Research. Recurrent topics in Mark Harland's work include Cancer Genomics and Diagnostics (16 papers), Cutaneous Melanoma Detection and Management (16 papers) and Melanoma and MAPK Pathways (13 papers). Mark Harland is often cited by papers focused on Cancer Genomics and Diagnostics (16 papers), Cutaneous Melanoma Detection and Management (16 papers) and Melanoma and MAPK Pathways (13 papers). Mark Harland collaborates with scholars based in United Kingdom, United States and Netherlands. Mark Harland's co-authors include D. Timothy Bishop, Julia Newton‐Bishop, Juliette A. Randerson‐Moor, Jack Cuzick, Elizabeth Pinney, Veronique Bataille, Nelleke A. Gruis, Sharon Brookes, Jérémie Nsengimana and Nicholas K. Hayward and has published in prestigious journals such as Molecular and Cellular Biology, Cancer Research and Oncogene.

In The Last Decade

Mark Harland

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Harland United Kingdom 23 840 672 300 251 224 43 1.3k
Karin Wadt Denmark 18 528 0.6× 701 1.0× 319 1.1× 298 1.2× 173 0.8× 65 1.4k
Delphine S. Ally United States 4 683 0.8× 634 0.9× 301 1.0× 124 0.5× 157 0.7× 4 1.1k
Zaida García‐Casado Spain 20 482 0.6× 782 1.2× 427 1.4× 85 0.3× 136 0.6× 79 1.3k
Xiaodong Liao China 12 442 0.5× 902 1.3× 303 1.0× 105 0.4× 155 0.7× 22 1.2k
Molly A. Taylor United States 18 624 0.7× 970 1.4× 510 1.7× 432 1.7× 102 0.5× 30 1.7k
Siddhartha Deb Australia 20 435 0.5× 660 1.0× 244 0.8× 189 0.8× 51 0.2× 48 1.3k
J F Flores United States 9 565 0.7× 552 0.8× 236 0.8× 123 0.5× 90 0.4× 11 968
Benjamin C. Calhoun United States 20 357 0.4× 529 0.8× 387 1.3× 53 0.2× 262 1.2× 72 1.3k
Karuppiah Kannan United States 13 427 0.5× 831 1.2× 146 0.5× 136 0.5× 113 0.5× 29 1.1k
Suhu Liu United States 18 476 0.6× 946 1.4× 333 1.1× 287 1.1× 83 0.4× 34 1.4k

Countries citing papers authored by Mark Harland

Since Specialization
Citations

This map shows the geographic impact of Mark Harland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Harland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Harland more than expected).

Fields of papers citing papers by Mark Harland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Harland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Harland. The network helps show where Mark Harland may publish in the future.

Co-authorship network of co-authors of Mark Harland

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Harland. A scholar is included among the top collaborators of Mark Harland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Harland. Mark Harland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Randerson‐Moor, Juliette A., John R. Davies, Mark Harland, et al.. (2024). Systemic Inflammation, the Peripheral Blood Transcriptome, and Primary Melanoma. Journal of Investigative Dermatology. 144(11). 2513–2529.e17. 3 indexed citations
2.
Davies, John R., Mark Harland, Rasha N.M. Saleh, et al.. (2023). Polymorphisms in Cyclooxygenase , Lipoxygenase , and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. Cancer Prevention Research. 16(11). 621–629. 6 indexed citations
3.
Ossio, Raúl, Mark Harland, Karen A. Pooley, et al.. (2022). Population-based analysis of POT1 variants in a cutaneous melanoma case–control cohort. Journal of Medical Genetics. 60(7). 692–696. 11 indexed citations
4.
Muralidhar, Sathya, Anastasia Filia, Jérémie Nsengimana, et al.. (2019). Vitamin D–VDR Signaling Inhibits Wnt/β-Catenin–Mediated Melanoma Progression and Promotes Antitumor Immunity. Cancer Research. 79(23). 5986–5998. 78 indexed citations
5.
Poźniak, Joanna, Jérémie Nsengimana, Jonathan P. Laye, et al.. (2019). Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma. Cancer Research. 79(10). 2684–2696. 43 indexed citations
6.
Filia, Anastasia, Alastair Droop, Mark Harland, et al.. (2019). High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material. Scientific Reports. 9(1). 8908–8908. 4 indexed citations
7.
Harland, Mark, Mia Petljak, Carla Daniela Robles‐Espinoza, et al.. (2015). Germline TERT promoter mutations are rare in familial melanoma. Familial Cancer. 15(1). 139–144. 43 indexed citations
8.
Bisio, Alessandra, Elisa Latorre, Virginia Andreotti, et al.. (2015). The 5′-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding. Oncotarget. 6(37). 39980–39994. 20 indexed citations
9.
Davies, John R., Yu‐Mei Chang, Helen Snowden, et al.. (2011). The determinants of serum vitamin D levels in participants in a melanoma case–control study living in a temperate climate. Cancer Causes & Control. 22(10). 1471–1482. 30 indexed citations
10.
Newton‐Bishop, Julia, Yu‐Mei Chang, Mark M. Iles, et al.. (2010). Melanocytic Nevi, Nevus Genes, and Melanoma Risk in a Large Case-Control Study in the United Kingdom. Cancer Epidemiology Biomarkers & Prevention. 19(8). 2043–2054. 70 indexed citations
11.
Jewell, Rosalyn, Caroline Conway, Angana Mitra, et al.. (2010). Patterns of Expression of DNA Repair Genes and Relapse From Melanoma. Clinical Cancer Research. 16(21). 5211–5221. 42 indexed citations
12.
Lang, Julie, Julia Newton‐Bishop, Mark Harland, et al.. (2010). A Flexible Multiplex Bead-Based Assay for Detecting Germline CDKN2A and CDK4 Variants in Melanoma-Prone Kindreds. Journal of Investigative Dermatology. 131(2). 480–486. 10 indexed citations
13.
Conway, Caroline, Samantha Beswick, Faye Elliott, et al.. (2010). Deletion at chromosome arm 9p in relation to BRAF/NRAS mutations and prognostic significance for primary melanoma. Genes Chromosomes and Cancer. 49(5). 425–438. 37 indexed citations
14.
Pjanova, Dace, Juliette A. Randerson‐Moor, Mark Harland, et al.. (2007). CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population. Melanoma Research. 17(3). 185–191. 22 indexed citations
15.
Newton‐Bishop, Julia, Mark Harland, & D. Timothy Bishop. (2006). The genetics of melanoma. British Journal of Hospital Medicine. 67(6). 299–304. 22 indexed citations
16.
Harland, Mark, Claire Taylor, Sylvia Bass, et al.. (2005). Intronic sequence variants of the CDKN2A gene in melanoma pedigrees. Genes Chromosomes and Cancer. 43(2). 128–136. 27 indexed citations
17.
Molven, Anders, Solrun J. Steine, Mark Harland, et al.. (2005). A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosomes and Cancer. 44(1). 10–18. 72 indexed citations
18.
Harland, Mark. (2001). A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Human Molecular Genetics. 10(23). 2679–2686. 77 indexed citations
19.
Newton‐Bishop, Julia, Rachel Wachsmuth, Mark Harland, et al.. (2000). Genotype/Phenotype and Penetrance Studies in Melanoma Families with Germline CDKN2A Mutations. Journal of Investigative Dermatology. 114(1). 28–33. 73 indexed citations
20.
Harland, Mark, Dorothy C. Bennett, Véronique Bataille, et al.. (1999). Mutation testing in melanoma families: INK4A, CDK4 and INK4D. British Journal of Cancer. 80(1-2). 295–300. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin Wadt Breakdown of academic impact, for papers by Delphine S. Ally Breakdown of academic impact, for papers by Zaida García‐Casado Breakdown of academic impact, for papers by Xiaodong Liao Breakdown of academic impact, for papers by Molly A. Taylor Breakdown of academic impact, for papers by Siddhartha Deb Breakdown of academic impact, for papers by J F Flores Breakdown of academic impact, for papers by Benjamin C. Calhoun Breakdown of academic impact, for papers by Karuppiah Kannan Breakdown of academic impact, for papers by Suhu Liu
Rankless by CCL
2026